Literature DB >> 30510790

The European Society of Thoracic Surgeons (ESTS) lung neuroendocrine tumors (NETs) database.

Pier Luigi Filosso1, Pierre Emmanuel Falcoz2, Paolo Solidoro3, Danilo Pellicano4, Stefano Passani4, Francesco Guerrera1, Enrico Ruffini1.   

Abstract

Histological characteristics and clinical behaviour define lung neuroendocrine tumors (NETs), which are classified into four groups: typical (TC) and atypical carcinoids (AC), large-cell neuroendocrine carcinomas (LCNCs) and small-cell lung cancers (SCLCs). Historically, outcome and treatment of these rare neoplasms have been based on small, usually mono-institutional clinical series. Furthermore, their rarity makes quite impossible to design randomised clinical trial to compare different treatments especially in unusual clinical presentations. In 2012, the European Society of Thoracic Surgeons (ESTS) launched a new working-group, specifically dedicated to lung NETs, with the aim to develop modern knowledge on biology and behaviour of these tumors, and to disseminate it within the scientific community. A dedicated retrospective database was at first developed and sent to all the ESTS centres interested to this project. More than 2,000 operated NETs cases have been rapidly collected, and they represented the clinical substrate of several published scientific studies. The retrospective data collection intrinsic limitations in term of patients' selection and treatment, along with the problem of possible missing data, were the reasons why the ESTS NETs working-group decided in 2015 to design and promote a new prospective database, employing the official ESTS platform. The aim of this review paper is to report the ESTS Lung NETs working-group history and to explain the architecture and use of the lung NETs databases.

Entities:  

Keywords:  Lung; neuroendocrine tumors (NETs); outcome; prospective database; retrospective database

Year:  2018        PMID: 30510790      PMCID: PMC6230831          DOI: 10.21037/jtd.2018.04.104

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  9 in total

Review 1.  Neuroendocrine tumors of the lung: an update.

Authors:  Natasha Rekhtman
Journal:  Arch Pathol Lab Med       Date:  2010-11       Impact factor: 5.534

2.  Prognostic model of survival for typical bronchial carcinoid tumours: analysis of 1109 patients on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours Working Group.

Authors:  Pier Luigi Filosso; Francesco Guerrera; Andrea Evangelista; Stefan Welter; Pascal Thomas; Paula Moreno Casado; Erino Angelo Rendina; Federico Venuta; Luca Ampollini; Alessandro Brunelli; Franco Stella; Mario Nosotti; Federico Raveglia; Valentina Larocca; Ottavio Rena; Stefano Margaritora; Francesco Ardissone; William D Travis; Inderpal Sarkaria; Dariusz Sagan
Journal:  Eur J Cardiothorac Surg       Date:  2015-01-05       Impact factor: 4.191

3.  Management of bronchial carcinoids: international practice survey among the European Society of Thoracic Surgeons.

Authors:  Pier Luigi Filosso; Francesco Guerrera; Pascal Thomas; Alessandro Brunelli; Eric Lim; Mariano Garcia-Yuste; Hisao Asamura; Konstantinos Papagiannopoulos; Inderpal Sarkaria; Federico Venuta
Journal:  Future Oncol       Date:  2016-06-15       Impact factor: 3.404

4.  Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†.

Authors:  Pier Luigi Filosso; Ottavio Rena; Francesco Guerrera; Paula Moreno Casado; Dariusz Sagan; Federico Raveglia; Alessandro Brunelli; Stefan Welter; Lucile Gust; Cecilia Pompili; Caterina Casadio; Giulia Bora; Antonio Alvarez; Wojciech Zaluska; Alessandro Baisi; Christian Roesel; Pascal Alexandre Thomas
Journal:  Eur J Cardiothorac Surg       Date:  2014-11-18       Impact factor: 4.191

5.  External Validation of a Prognostic Model of Survival for Resected Typical Bronchial Carcinoids.

Authors:  Maria Cattoni; Eric Vallières; Lisa M Brown; Amir A Sarkeshik; Stefano Margaritora; Alessandra Siciliani; Andrea Imperatori; Nicola Rotolo; Farhood Farjah; Grace Wandell; Kimberly Costas; Catherine Mann; Michal Hubka; Stephen Kaplan; Alexander S Farivar; Ralph W Aye; Brian E Louie
Journal:  Ann Thorac Surg       Date:  2017-08-16       Impact factor: 4.330

Review 6.  Multidisciplinary management of advanced lung neuroendocrine tumors.

Authors:  Pier Luigi Filosso; Piero Ferolla; Francesco Guerrera; Enrico Ruffini; William D Travis; Giulio Rossi; Paolo Olivo Lausi; Alberto Oliaro
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

Review 7.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

8.  Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: experience of two decades of cancer registry.

Authors:  Catharina M Korse; Babs G Taal; Marie-Louise F van Velthuysen; Otto Visser
Journal:  Eur J Cancer       Date:  2013-01-23       Impact factor: 9.162

9.  A 5-decade analysis of 13,715 carcinoid tumors.

Authors:  Irvin M Modlin; Kevin D Lye; Mark Kidd
Journal:  Cancer       Date:  2003-02-15       Impact factor: 6.860

  9 in total
  6 in total

1.  External Validation of a Prognostic Score for Survival in Lung Carcinoids.

Authors:  Marco Chiappetta; Diomira Tabacco; Carolina Sassorossi; Isabella Sperduti; Giacomo Cusumano; Alberto Terminella; Ludovic Fournel; Marco Alifano; Francesco Guerrera; Pier Luigi Filosso; Samanta Nicosia; Filippo Gallina; Francesco Facciolo; Stefano Margaritora; Filippo Lococo
Journal:  Cancers (Basel)       Date:  2022-05-25       Impact factor: 6.575

Review 2.  [Modern sonographic imaging of abdominal neuroendocrine tumors].

Authors:  V Schwarze; C Marschner; S Grosu; J Rübenthaler; T Knösel; D-A Clevert
Journal:  Radiologe       Date:  2019-11       Impact factor: 0.635

3.  Administrative and clinical databases: General thoracic surgery perspective on approaches and pitfalls.

Authors:  Biniam Kidane; Elliot Wakeam; Robert A Meguid; David D Odell
Journal:  J Thorac Cardiovasc Surg       Date:  2021-03-19       Impact factor: 6.439

Review 4.  Systemic treatment for lung carcinoids: from bench to bedside.

Authors:  Mariangela Torniai; Laura Scortichini; Francesca Tronconi; Corrado Rubini; Francesca Morgese; Silvia Rinaldi; Paola Mazzanti; Rossana Berardi
Journal:  Clin Transl Med       Date:  2019-07-04

5.  NEP-Score Thresholds Predict Survival of Patients With Bronchial Carcinoids.

Authors:  Irene Gagliardi; Mario Tarquini; Maria Rosaria Ambrosio; Elisa Giannetta; Patricia Borges de Souza; Roberta Gafà; Aldo Carnevale; Paola Franceschetti; Maria Chiara Zatelli
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-08       Impact factor: 5.555

6.  99mTc-EDDA/HYNIC-TOC is a New Opportunity in Neuroendocrine Tumors of the Lung (and in other Malignant and Benign Pulmonary Diseases).

Authors:  Vittorio Briganti; Vincenzo Cuccurullo; Valentina Berti; Giuseppe D Di Stasio; Flavia Linguanti; Francesco Mungai; Luigi Mansi
Journal:  Curr Radiopharm       Date:  2020
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.